Generics - Generics


Current filters:


Popular Filters

1126 to 1141 of 1141 results

US medicines spending rose 3.7% in 2011, held back by healthcare reforms, IMS study reveals


Total health care spending on medicines in the USA increased 3.7% to $320 billion in 2011, a year which…

BiotechnologyGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceuticalPricing

Watson confirms Lumigan and Latisse patent challenges; favorable Sanctura ruling


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) has confirmed that its subsidiary, Watson Laboratories,…

AllerganGenericsGenito-urinaryLatisseLegalLumiganOphthalmicsPatentsSanctura XRWatson Pharmaceuticals

Head of NAFDAC advocates 200 billion naira lifeline for Nigerian pharma firms


The Director-General of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC),…

FinancialGenericsPharmaceuticalRest of the World

BASF and Catalent join forces to address NME bioavailability challenges


Privately-held USA-based Catalent Pharma Solutions has joined forces with German drug giant BASF (BAS:…

BASFCatalent PharmaGenericsPharmaceuticalResearch

Novartis expands transplant portfolio with first branded generic tacrolimus


Swiss drug major Novartis has announced the US introduction and availability of Hecoria (tacrolimus)…

Astellas PharmaGenericsHecoriaImmunologicalsMarkets & MarketingNorth AmericaNovartisPrografSandoztacrolimus

Poland breaking EU law by allowing unauthorized cheaper drugs


Polish legislation authorizing the placing on the market of foreign medicinal products lacking authorization…

EuropeGenericsLegalMarkets & MarketingPharmaceuticalRegulation

Australian PBS prices slash in effect; clinical trial investment


On April 1, 2012, in Australia, publicly funded generic medicines on the Pharmaceutical Benefits Scheme…


Lower drugs costs and insurance may help India achieve affordable medicines


The next few years will spell considerable growth and change for the Indian health insurance industry,…


US Court upholds AstraZeneca Seroquel XR patent


In some good news for the company, Anglo-Swedish drug major AstraZeneca (LSE: AZN) announced last night…

Anchen PharmaceuticalsAstraZenecaGenericsMylan LaboratoriesNeurologicalNorth AmericaPatentsPharmaceuticalSeroquel XRTorrent Pharmaceuticals

Horizon Pharma sues Par for infringing Duexis patent


Horizon Pharma (Nasdaq: HZNP) has filed a patent infringement lawsuit in the US District Court for the…

DuexisGenericsHorizon PharmaLegalNeurologicalNorth AmericaPar PharmaceuticalPatents

Sanofi and Bayer consider Russian expansion, product launches


Two European drug majors - France-based Sanofi (Euronext: SAN) and German company Bayer (BAY: DE) have…

BayerEuropeGenericsInsulinMarkets & MarketingPharmaceuticalSanofi

1126 to 1141 of 1141 results

Back to top